steadily
pharmacy
emil
arg
lee
expert
thermogenic
alauddin
proven
future
image
kinase
record
108349
eur
parameter
then
rest
walsum
0050
zhao
99mtc
qiao
analogue
van
extracted
immune
comparative
about
early
PC9
distinguishing
release
synthesi
jia
transperineal
complexity
tracer'
nuclear
aim
dependence
liver
oxycodone
shiba
carrying
zhang
assessed
altering
grime
bmc
TKI
018
overexpression
also
pyrimidine
vattimo
LP2S
IRS
death
ddy
zhu
302
fluorophenyl
optimally
overall
2008
utilized
perspective
place
1003
sawazaki
despite
polyethylene
000
cpb
related
peak
A431
maximum
1016
checkpoint
guo
here
interfere
against
indicated
retention
develop
immediately
mamat
unknown
bioorg
limit
stable
model
first
inability
molecule
around
organ
curve
2017
evaluate
term
baseline
allow
acquired
tracer
telese
see
BMC
abourbeh
torren
jiang
cold
fluorescence
promise
exces
hashimoto
banerjee
ono
potency
dimethylamine
den
morpholino
siegel
either
casagrande
absorption
neuropharmacology
fold
reasonable
would
second
pal
beneficial
leading
fundamental
addition
due
before
who
re
good
self
reduction
care
recovery
warrant
universita
toward
increased
junior
300
accumulation
activating
cell
dirik
employed
exhibited
cmet
implying
ar500362y
rociletinib
modulation
adv
radiopharmaceutical
shao
become
double
examined
separate
355
131
1012
injecting
ph15040450
exp
vitro
radiosynthesi
preclinical
specifically
identified
not
014
account
reviewed
6_12
site
TK
chosen
US
implie
varied
condition
clas
decrease
namely
direct
reache
1186
wistuba
2500
evaluated
takeda
large
1080
reached
receptor
ATP
test
suzuki
cetuximab
elimination
http
effectively
anesthesia
subjected
nonspecific
QG56
NH
radiobrominated
tendency
mutated
dwi
slobbe
particularly
consideration
4470
capacity
qin
curr
transplanted
17588359221146131
826
PK
2019
skin
corroborate
six
statistically
concentration
remained
4449
approximately
molecular
okazawa
therapeutic
efflux
liao
positron
compete
reversible
miyake
combination
neuropharm
lung
greatest
focu
latu
issue
identical
007
1686
represent
440
only
shi
database
license
nurul
make
339
fraction
PL
purpose
bull
v10
among
2021
done
selectively
PET'
effectivenes
proteomic
structurally
watanabe
new
2305
eto
each
equivalent
promising
265383
carrier
might
exclusion
CA
very
shown
precise
simple
needed
reported
unimodal
retained
inclusion
unchanged
epidermal
plateau
selective
noticeable
29832
preference
reduced
meanwhile
L9
advantageou
hydrazinylnicotinate
yeh
fluorophenylamino
detection
125I
displayed
maintained
kawasaki
mice
course
PHY
high
published
without
during
niessen
HPLC
novel
manually
threefold
1177
40732
muscle
safe
3322
los
mol
play
jin
hoek
han
discussion
singh
there
innovative
decreased
morpholin
fibroblast
excreted
redistribution
erlotinib'
schreur
detecting
left
based
da
stehle
bone
131I
odani
roth
mukhapadhyay
discoverie
roy
cannabi
bound
relatively
afatinib'
responsive
cancers12020371
cellular
gradually
A548
initial
diagnosi
well
5988
dual
known
scenario
summary
animal
taken
704
sex
3390
1002
anilinoquinazoline
acquisition
mbq
pattern
identification
affinity
afatinib
org
286
yokokawa
reaching
imaging
kiyono
entire
motor
CT
male
slower
424
1596030
jnumed
wulandari
expresse
PC14
replacing
throughout
radioactivity
vugt
occupying
beige
kawahara
probe
transl
masdiana
greater
PI
chen
radioiodine
radionuclide
2005
559
NCI
kanai
108
change
1126
rei
01679
ph14030256
incubation
deficit
slightly
volume
pursued
table
according
ratio
used
highest
count
subramanian
56085116100
identifying
37132015000004531
presence
ohmomo
implication
chance
gene
found
since
soo
variability
vecchio
binding
produced
294
313
ethoxy
2022
lin
attribution
fundamentally
minimal
102581
over
modulating
megarezky
strain
successfully
per
out
H441
attenuation
benner
doe
erlotinib
1608
1053
experiment
takeyama
shan
meng
necessary
fujisawa
kinetic
interest
treated
clearance
umi
evaluation
s12915
actually
much
minor
weber
acknowledgment
dji055
APP
expressing
undergoing
continue
track
huesti
open
2014
dynamic
feng
pomper
carried
prevented
did
activity
level
input
molecules25122914
21037
QAR
structural
positive
nomura
s40336
b13
near
ijc
discovery
wherea
transcriptomic
covalently
renal
right
liquid
impact
grant
already
bearing
targeting
smit
caused
transfected
mahler
assessment
validated
ochi
understand
40740
metab
122
flore
01139
area
absolute
subsequent
lepera
quinazoline
001
testing
hour
several
amine
differentiate
women
lim
accepted
L858R
clearer
les
small
2011
com
s11307
tested
kuo
approache
george
acces
radiotracer
portion
favored
derivative
mouse
computed
retain
rotarod
radiosensitizer
FTP2
day
montesino
through
bromoanilino
other
BRIAC145
extensive
ala
nucl
T790M
therapy
specific
seen
using
0007
use
men
bind
version
summarized
another
135
determining
low
696
nature
MPG
najjar
pre
contrast
11CH
agent
usually
laboratory
sexe
ilar
earlier
makassar
kai
predicted
group
shigematsu
associated
carcinoma
ther
HER2
making
regardles
observed
further
photon
PEG
yagi
mean
AZD9291
research
some
glu
06183
case
1007
113503
fluoro
extraction
urine
tong
371
RESCA
fong
stability
show
tumor
slaughtered
inst
body'
repeated
rapid
del
data
selectivity
following
visualization
department
program
pretreated
glycol
tahir
carbon
ferroptosi
harbouring
shamni
ha
inorganic
windhorst
shen
step
value
A750
improved
create
ijms24032505
identify
koirala
akagi
ogawa
human
demonstrated
limitation
helpful
commonly
volgin
unlabeled
winuprasith
leu
ministry
biological
usefulnes
collected
imply
muslim
may
bpb
αvβ3
inshishian
must
capable
estimation
isotopologue
cancer
cell'
our
375
549359
search
978
FDG
metabolomic
expression
rank
different
fang
comparing
tomography
PG
2505
background
study
lan
BY
propyl
within
124I
statistic
tomoike
wagle
still
ding
stomach
gazdar
pair
145
studie
continued
alati
radiolabeled
balatoni
lodhi
dosage
osimertinib
worldwide
krasnykh
constant
eaan8840
kimura
semin
1021
verlaan
adolescent
a750del
non
it
but
acrylamide
month
SUV
integrin
methylindole
huang
extra
micro
general
predict
reveal
detect
yexcr
metastatic
radiobromine
023
phenoxy
oncotarget
heideman
could
NY
shavrin
whether
1073
castro
creative
18F
18632
conventional
ito
cho
state
activation
14737140
challenging
appropriately
substantially
administered
than
method
normal
079
comprehensive
most
diagnostic
washout
6369
increase
hydrophobic
heterogeneity
BALB
121
ACS
resistance
steady
mutational
amide
determined
received
similar
1603
rate
takigawa
why
sumatera
young
doyle
transporter
logarithmic
814
harbor
gelovani
correspondence
CC
million
750
grievink
2147
required
shimizu
1248
radioiodinated
indicate
breast
O11CH3
tissue
injected
highly
caac
three
trapped
generate
H520
accounted
endometrial
del19
wild
tetrahydrocannabinol
00559
yamane
more
just
drug
martinez
kidney
6b00520
soft
s13550
primary
excretion
selection
fate
meo
developed
structure
E5
xiao
having
stigter
oncol
management
song
explaining
iodophenyl
culture
percentage
pyrido
urol
funding
marker
365
piomelli
route
lack
unfavorable
target
dai
designated
mei
finding
beside
numerou
H1299
aan8840
viewing
medan
cause
oet
sample
s12943
negative
catabolism
17251
abstract
biomed
therefore
fluoroethoxy
susceptible
indirect
reducing
418
acknowledge
between
injection
intestine
nishii
strong
scanning
muammar
peptide
support
nanobody
amsu
when
fluorinated
ahmed
sensitive
wen
2ftlcr
mao
block
33263
potential
they
med
brown
moderate
deletion
EGF
sensitizing
547
compared
tagged
s00259
heart
post
sci
flank
approx
absence
nonetheles
022
excised
longer
processe
investigated
00081
world
2967
WT
current
bra
way
prior
dimethoxyquinazoline
400
should
biology
point
1613
functioned
schuit
747
015
sampling
higher
emitting
quinazolin
existing
pratama
certain
previou
bait
RGD
administration
down
asses
studied
cai
resulted
intravenou
251
bmcl
pharmacokinetic
vivo
additional
will
least
ILAR
modestly
larger
humana
radiolabeling
lett
MIRC213
specificity
all
because
500
scopu
dropped
significantly
177
scifinder
gram
purity
incubated
number
characterized
metabolism
oxy
proc
ottavio
determine
600
dose
kinuya
fukazawa
fuchigami
beaino
thu
important
IV
EJNMMI
hemodialysi
morpholinopropoxy
therapie
preserved
slight
1590
rowe
346
treatment
international
2318
advance
semnuclmed
investigation
1286
necrotic
invasive
result
scitranslmed
rep
3167
adipose
pharmaceutical
context
annually
created
phase
ishiguro
miyazaki
concluded
deteriorated
under
creativecommon
behavioral
s11934
256
exhibit
toyooka
magnitude
differed
had
author
PET
nearly
conclude
chloro
i19
technique
mousa
int
chemistry
radio
bohn
11C
line
1089
appear
maurer
fluor
cheng
conducted
2015
schwab
biol
female
H3225
hirata
kawai
berg
measure
noteworthy
medicine
proces
describe
1010744108
difference
herz
encouragement
appl
prognostic
fonti
many
xenografted
2013
muzakkir
ability
adequate
100
location
120
operate
inhibitor
quantitative
360
2023
659
tyrosine
chemical
gonzalez
approach
estimated
overcome
distinguishable
itamar
c18
appropriate
adult
clin
ERBB4
gefitinib
demonstrate
monitoring
accumulating
takahashi
jemal
142
biointerface
21763
zappa
12998
aminuddin
TAC
kujtan
keyword
2914
0088
assay
utara
write
makino
active
their
showing
need
labeled
CO
comparison
after
kong
fawwaz
considerably
wang
detected
yang
exon
effective
S416737
pharm
SPECT
application
iommelli
pna
decision
emulsion
western
given
cultured
0716
304
valuable
total
them
scan
reduce
ann
wilcox
05967
BRIAC135
sequencing
analysi
H1650
1217
lipophilicity
principal
prostate
blotting
screening
period
1210
martin
barrier
indicating
ome
furthermore
E746
methylbenzenesulfonate
regarding
same
iodo
off
CMR
radioactive
FEE
into
autoradiography
methoxyquinazolin
type
cros
natl
showed
indonesia
khomein
237
media
jnci
NSCLC
clear
variation
full
figure
soghomonyan
vector
mutation
nishimura
leal
hydrochloride
2020
mutant
vanden
include
while
zhou
removing
faster
accumulate
fat
s1806
450
animal'
wjcc
influence
increasing
iodoani
characterize
two
rev
alf
decaze
acid
lowest
better
246
dongen
biophysical
pancrea
inhibited
ijn
H358
104
minna
complement
138
labeling
such
663
notably
although
mishiro
mishani
somewhat
individual
consistent
H1975
comparable
eliminated
kaye
efficacy
development
arimitsu
twofold
lower
modified
declare
silva
predictive
one
statu
lino
establishing
HCC827
generation
immunotherapy
metabolic
minimally
slow
substantial
advisable
acros
HN
faculty
nucmedbio
pang
cannabinoid
01757
diethoxy
control
modification
109635
0042
insertion
almost
distinguish
brain
gambhir
acad
insufficient
6360
H3255
yloxy
even
chem
protein
picture
hepatobiliary
blocking
education
triple
acc
124
2018
contralateral
PD153035
wa
receiving
delineated
supported
discovered
rat
stated
significant
naka
irreversible
obtained
infrared
fast
xenobiotics'
preferential
fardon
mechanism
422
review
biodistribution
biointerfaceresearch
iressa
2016
likely
medium
pascasio
0072
time
doi
CEACAM5
conclusion
response
eliminate
substitution
xenograft'
undetected
ethyl
2024
containing
pneumol
depending
targeted
emission
poot
calculate
EGFR
min
except
1609
washable
compound
2662
technology
owing
both
york
enhanced
nanomed
nanomaterial
liu
1093
quantify
HYNIC
feature
deemed
resulting
work
yoshimoto
heterogeneou
pubmed
A549
kagawa
uptake
growth
xenograft
288
introduction
084
prevent
MI
inhibit
miller
colorectal
four
popular
280
distribution
5985
blood
0205
article
occur
harboring
surg
distinct
revolutionary
L747
propertie
651
bioavailability
pretreatment
suggest
saparuddin
hildebrandt
ID
variou
performed
third
report
explained
hsieh
optimization
hoegnaesbacka
followed
amino
nakanishi
nagasaki
reasonably
lope
domain
standard
accumulated
reference
respond
PEG6
pegylated
sun
minute
patient
acsmedchemlett
anticancer
mcclement
oka
rosa
diagnose
sensitivity
686
biopsy
021
conflict
FAPI
role
okuda
solca
1155
inhibition
spleen
clinical
however
kooijman
guglielmo
typical
single
salim
IPQA
saji
respectively
strategy
factor
date
common
revealed
68ga
distributed